Compare Johnson & Johnson (JNJ) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Valero Energy Corporation — how do they compare? Johnson & Johnson trades at $248.08 (market cap $598.96B), while Valero Energy Corporation trades at $314.86 (market cap $93.03B). The key difference: Johnson & Johnson is far larger — about 6.4× Valero Energy Corporation's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | VLO | |
|---|---|---|
Market Cap | $598.96B | $93.03B |
Volume | 6,156,228 | — |
Sector | Health | Energy |
52-Week High | $267.24 | $313.31 |
52-Week Low | $164.36 | $131.77 |
Enterprise Value | $631.90B | $98.79B |
Dividend Yield | 2.15% | 1.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
Valero Energy (VLO) trades at $314.81, up 1.67% on the day, with strong technical momentum and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.22 surpassing expectations of $3.16. Revenue declined to $122.69 billion in 2025, but net income margin held at 3.37%, supported by robust refining margins. Recent news highlights strong fuel demand and elevated crack spreads benefiting Valero's outlook.
The outlook remains positive given earnings beats, analyst buy ratings (55.55%), and refining margin tailwinds. However, declining revenue trends, high RSI levels suggesting overbought conditions, and exposure to volatile energy markets pose risks. The consensus price target of $276.22 implies potential downside from current levels, requiring careful monitoring of Q2 2026 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
